BANGKOK, June 17 (The Nation Thailand/ANN): Thailand's Government Pharmaceutical Organisation (GPO) is expected to start producing the antibody nasal spray solution to prevent Covid-19 by the third quarter of this year.
“GPO’s Viral Vaccine Division under the Department of Biological Products received a certificate of registration on June 6, allowing it to start manufacturing the solution containing the human IgG1 Anti-SARS-CoV-2 antibody,” GPO director Rangsee Padlee said.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
